Skip to main content
    G

    GE HealthCare Technologies Inc. (GEHC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $81.84
    -1.12 (-1.35%)

    Market Cap: $37.51B

    Last updated: Nov 17, 2026 at 4:41 PM ET

    GE HealthCare Technologies Inc. (GEHC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    GE HealthCare Technologies (GEHC) has a market cap of $37.51B and an enterprise value of $44.63B. Its return on invested capital of 11.86% compares with a 7.46% median across 10 similar companies.

    Total Valuation

    Enterprise value is 18.98% above the market cap, as debt exceeds cash.

    Market Cap$37.51B
    Enterprise Value$44.63B
    Latest price (Nov 17, 2026)$81.84

    Key Dates

    The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 23, 2026.

    Next Earnings DateFeb 8, 2027 (expected)
    Last Earnings DateOct 28, 2026
    Last Ex-Dividend DateOct 23, 2026
    Last Payment DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.22% in the quarter ended Sep 30, 2026 and shrank 0.55% a year over 2 years.

    Shares Outstanding452.00M
    Shares Change (YoY)-0.88%
    Shares Change (QoQ)-0.22%
    Share Count Growth (2Y CAGR)-0.55%

    Valuation Ratios

    Sales and book value multiples are 1.7x and 3.2x. Its year-end P/E ranged from 17.0x to 19.6x from 2023 to 2025.

    P/E Ratio16.7x
    Forward P/E16.0x
    P/S Ratio1.7x
    Forward P/S1.7x
    P/B Ratio3.2x
    P/FCF Ratio19.6x
    P/OCF Ratio15.5x
    PEG Ratio2.1

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 11.5x EBITDA and 23.4x free cash flow.

    EV / Earnings20.2x
    EV / Sales2.1x
    EV / EBITDA11.5x
    EV / EBIT13.9x
    EV / FCF23.4x

    Price Statistics

    The stock is up 12.04% over 52 weeks and trades 15.09% above its 50-day average.

    Beta (1Y)0.64
    52-Week Change+12.04%
    1-Month Change+17.38%
    3-Month Change+9.74%
    6-Month Change+32.98%
    Total Return (1Y)+12.24%
    Total Return (3Y CAGR)+4.05%
    Return vs SPY (1Y)+3.85%
    Max Drawdown (1Y)-32.47%
    Max Drawdown (3Y)-37.35%
    Sharpe Ratio (1Y)0.40
    Correlation with SPY (1Y)0.25
    50-Day Average$71.11
    200-Day Average$69.91
    52-Week Range$58.68 to $89.59
    RSI (14 Days)63.5
    Average Volume (20 Days)4.34M

    Price chart

    Financial Position

    Current assets cover 1.30x current liabilities, and total debt is 0.86x shareholder equity.

    Current Ratio1.30x
    Quick Ratio1.01x
    Debt / Equity0.86x
    Debt / EBITDA2.60x
    Debt / FCF5.28x
    Interest Coverage7.32x

    Returns and Efficiency

    Return on invested capital is 11.86% and return on equity is 19.02% over the last 12 months.

    Return on Equity (ROE)19.02%
    Return on Assets (ROA)5.76%
    Return on Invested Capital (ROIC)11.86%
    Return on Capital Employed (ROCE)10.85%
    ROE (5Y Average)20.49%
    ROA (5Y Average)6.57%
    Asset Turnover0.58x
    Inventory Turnover5.08x
    Receivables Turnover5.54x
    Cash Conversion Cycle46 days

    Taxes

    Income tax took 20.22% of pretax income over the last 12 months.

    Income Tax (TTM)$560.00M
    Effective Tax Rate20.22%

    Scores

    GEHC has an Altman Z-Score of 2.01, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score2.01
    Altman Z ZoneGrey
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $21.64B over the last 12 months is up 6.87% from the 12 months before.

    Revenue$21.64B
    Revenue Growth (YoY)+6.87%
    Gross Profit$8.64B
    Operating Income$2.89B
    Pretax Income$2.77B
    Net Income$2.21B
    EBITDA$3.83B
    EBIT$3.21B
    Reported EPS (TTM)$4.90

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 30.26% of the $38.37B in total assets.

    Cash and Equivalents$2.85B
    Total Debt$9.97B
    Net Debt$7.12B
    Net Debt Per Share$15.75
    Working Capital$2.68B
    Shareholder Equity$11.61B
    Book Value Per Share$25.69
    Tangible Book Value-$5.34B
    Total Assets$38.37B
    Total Liabilities$26.51B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $526.00M of capital spending, operating cash flow left $1.89B of free cash flow.

    Operating Cash Flow$2.42B
    Capital Expenditures$526.00M
    Free Cash Flow$1.89B
    FCF Per Share$4.18
    Depreciation and Amortization$622.00M
    Dividends Paid$64.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 13.34%, against a 5-year average of 13.77%.

    Gross Margin39.94%
    Operating Margin13.34%
    Pretax Margin12.80%
    Net Margin10.21%
    EBITDA Margin17.70%
    EBIT Margin14.83%
    FCF Margin8.73%
    Gross Margin (5Y Average)40.43%
    Operating Margin (5Y Average)13.77%
    Net Margin (5Y Average)10.58%

    Growth

    Revenue grew 3.99% a year over 3 years, and EPS 2.77% a year.

    Revenue Growth (3Y CAGR)+3.99%
    Revenue Growth (5Y CAGR)+3.74%
    EPS Growth (3Y CAGR)+2.77%
    FCF Growth (3Y CAGR)-5.84%
    FCF Growth (5Y CAGR)+1.06%
    Operating Income Growth (3Y CAGR)+3.09%
    Book Value Per Share Growth (2Y CAGR)+20.33%

    Revenue and profit by year

    Dividends and Yields

    GEHC pays out 2.71% of earnings as dividends.

    Dividend Per Share (Annual)$0.16
    Dividend Yield0.20%
    Payment ScheduleQuarterly
    Payout Ratio2.71%
    FCF Payout Ratio3.39%
    Earnings Yield5.99%
    FCF Yield5.11%
    Buyback Yield0.75%
    Shareholder Yield0.92%

    Full dividend history

    Peer Position

    Against 11 similar companies, GEHC has the 9th highest P/E.

    P/E Ratio16.7x vs 22.0x median
    P/S Ratio1.7x vs 3.6x median
    ROIC11.86% vs 7.46% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.87% vs +9.89% median
    Dividend Yield0.20% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.44% and EPS growth at 9.61% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.44%
    EPS Growth Forecast (2Y CAGR)+9.61%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GEHC

    What is GEHC's market cap?

    GE HealthCare Technologies has a market cap of $37.51B. Its enterprise value, which adds debt and subtracts cash, is $44.63B.

    What is GEHC's P/E ratio?

    GE HealthCare Technologies has a trailing P/E ratio of 16.7x and a forward P/E of 16.0x.

    How many shares of GEHC are outstanding?

    GE HealthCare Technologies has 452.00M shares outstanding. The count is down 0.88% from a year earlier.

    Does GEHC pay a dividend?

    Yes. GE HealthCare Technologies pays $0.16 a share a year, a dividend yield of 0.20%.

    How much debt does GEHC have?

    GE HealthCare Technologies has $9.97B of total debt and $2.85B of cash and equivalents, a net debt position of $7.12B.